LondonThe human parathyroid gland, which regulates the level of calcium in the blood, from from the gills of fish, according to researchers from King’s College London, human parathyroid gills gills .

King’s College LondonKing’s College London is one of the oldest and largest colleges of the University of London with some 13,400 students and more than 5,000 students in ten schools of study. It is in the top group of five universities for research earnings and has an annual turnover of about? 320 million and revenues from research grants and contracts of more than? 90 million . King is a member of the Russell Group, a coalition of major research-based universities in the UK.

online drugstore

When developing the tests, said. Letai team will work isolated mitochondria of cancerous cells, be protein fragments are protein fragments – peptides – which are known to to interact with the survival of molecules such Bcl-2. If they interact, then the cell is has primed of dying, and the test will notice which of the survivability molecules are holds the cells alive, he added. Then you know that kill the cell is, you might Bcl-2 target. Researchers tests test BH3 profiling because the array of protein fragments, known as BH3 domains. Letai which work is ongoing for which laboratories automation profiling operational view more, overlooking a time when there on a routine basis could be used to determine the susceptibility by patients protein forms of cancer to compounds BCL-2 and related anti Death evaluate antagonized. – This is the an entirely new class of drugs and have that potential to be a important complement, like us against cancer, he said.

The company develops itso is development of medicines company focusing on discovering new pharmaceutical substances to combat cancer and women’s health. The company has two drugs in clinical trials. MF101 in phase two of the quality of life of conditions of associated with menopause and BZL101 in phase 1/2 for the treatment of advanced breast cancer. The company has built an additional pipeline of drugs in developing on breast cancer, pancreatic cancer and other climacteric disorders with a total surface of 5 drug candidates expected to up his during clinical trials in late 2007. The company develops its products in close collaboration with leading U.S. Academic research centers, including the University of California, San Francisco, University of Colorado Health Sciences Center, University of California, Berkeley, and the University of Texas Southwestern Medical Center in Dallas, for more information, please visit:.

Other articles from category "mental":

Random articles